miRNA Tools and Services Market - Clinical Aspects, Review, Survey Report And Synthesis 2022

MicroRNAs (miRNA) are a class of non-coding RNAs that play an important role in the regulation of genetic expressions. These molecules function at the post-transcription level and modify the expression of about 30% of all genes encoding mammalian proteins. The use of bioinformatics and technologically advanced systems (such as NGS) and the increased incidence of chronic disorders drive market growth.

In addition, it is anticipated that the ability of miRNAs to act as diagnostic biomarkers and predictors of drug response will boost the demand for miRNA. However, the challenges related to the quantification and development of internal miRNA research tools, such as microarrays, restrict market growth.

Get Access to TOC / Sample Report @ https://www.alliedmarketresearch.com/request-sample/2103?utm_source=openpr_ss

The global market was valued at $146 million in 2015 and is expected to garner $620 million by 2022, registering a CAGR of 23.4% during the forecast period 2016 - 2022. Research tools segment held the nearly four-fifths share of the total market in 2015.

It is expected that the qRT-PCR technology segment will maintain its dominant position throughout the period of analysis due to the increase in the incidence of chronic diseases such as cancer and cardiovascular disorders. The increased demand for the identification of miRNA in different organisms and their associated role as a diagnostic biomarker for the disease also drives market growth.

The research segment and academic institutes dominated the market with more than two-fifths of the total market in 2015. This is mainly attributed to the increase in research projects undertaken to test the capacity of miRNA as candidates for biomarkers of diseases.

Have Queries? Ask us @ https://www.alliedmarketresearch.com/purchase-enquiry/2103?utm_source=openpr_ss

The major companies profiled in the report include QIAGEN (Exiqon), Thermo Fisher Scientific Inc., Illumina, Inc., Agilent Technologies, GE Healthcare Dharmacon Inc., GeneCopoeia, Inc., Promega Corporation, Bio-Rad Laboratories, Inc., Merck & Co., Inc., and New England Biolabs.

Key Findings of the Study:

• Research tools led the global miRNA tools and services market and accounted for nearly four-fifths of the total market in 2015.

• Functional studies services segment is projected to grow at the highest CAGR of 31.2% during the forecast period.

• CROs is the fastest growing segment and is expected to grow at a CAGR of 27.4% during the forecast period.

• qRT-PCR technology segment occupied nearly one-third of the market in 2015.

• In 2015 Japan was the major shareholder and accounted for almost one-third of the Asia-Pacific market.

Browse More Details of Report @ https://www.alliedmarketresearch.com/press-release/mirna-tools-and-services-market.html

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.